JANX vs GILD: Which Stock is Better?
Side-by-side comparison of Janux Therapeutics Inc and Gilead Sciences Inc in 2026
JANX
Janux Therapeutics Inc
$15.24
GILD
Gilead Sciences Inc
$139.03
Key Metrics Comparison
| Metric | JANX | GILD | Winner |
|---|---|---|---|
| Market Cap | $906.39M | $172.51B | GILD |
| P/E Ratio | N/A | 20.50 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | 21.8% | 0.0% | JANX |
| Gross Margin | -1159.0% | 78.8% | GILD |
Analyze JANX
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is JANX or GILD a better investment?
Comparing JANX and GILD: Janux Therapeutics Inc has a market cap of $906.39M while Gilead Sciences Inc has $172.51B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between JANX and GILD?
JANX (Janux Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: JANX or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: JANX or GILD?
JANX has higher revenue growth at 21.8% vs 0.0% for GILD.
Which company is more profitable: JANX or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to -1159.0% for JANX.
Which is the larger company: JANX or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $172.51B compared to $906.39M for JANX.
Should I buy JANX or GILD in 2026?
Both JANX and GILD have investment merit. JANX trades at $15.24 while GILD trades at $139.03. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between JANX and GILD stock?
Key differences: Market Cap ($906.39M vs $172.51B), P/E Ratio (N/A vs 20.5x), Revenue Growth (21.8% vs 0.0%), Gross Margin (-1159.0% vs 78.8%).